This information is provided by the WHO International Clinical Trials Registry and is current at 26 October 2015.
Currently Recruiting
- United Kingdom – Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease
- United Kingdom – Systemic therapy for vulval erosive lichen planus
- Brazil – Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser
- United States – Clobetasol Propionate Versus Radiofrequency CO2 Laser for the Treatment of Lichen
- United States – Genomics and Proteomics of Lichen Sclerosus
Not Recruiting
- United States – Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus
- Canada – Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus
- Germany – Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus
- Switzerland – Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus
Authorised
- Netherlands – The use of antibiotics in therapy resistant Lichen Sclerosus patientes
- Belgium – Etude de l’efficacité thérapeutique de la photothérapie dynamique (PDT) dans le lichen scléreux génital et les dysplasies génitales résistantes aux traitements conventionnels (‘Study the therapeutic efficacy of photodynamic therapy (PDT) in genital lichen sclerosus and genital dysplasias resistant to conventional treatments’)